期刊文献+

Th1/Th2在慢性乙型、丙型肝炎中的作用 被引量:2

Roles of Th1/Th2 in chronic hepatitis B and chronic hepatitis C
原文传递
导出
摘要 病毒性肝炎的发病及转归与细胞免疫机制有很密切的关系。辅助性T细胞(Th)是体内一类重要的调节细胞,根据其产生细胞因子的不同分为Th1和Th2亚型,分别参与调节细胞免疫和体液免疫。Th1和Th2细胞在病毒性肝炎中发挥重要作用,Th1/Th2失衡引起病毒性肝炎慢性化。采用单种细胞因子纠正Th1/Th2失衡方法在慢性乙型、丙型肝炎临床治疗中的研究进展,为治疗慢性病毒性肝炎提供了新思路。 There is a close relationship between the onset and prognosis of viral hepatitis and cell immune mechanisms.T helper Cells is one of an important kind of immune modulation ceils. According to the its production of cytokines ,T helper cells can be divided into two subgroups, Th1 and Th2, which participate in the modulation of cell and humoral immune, respectively. Thl and Th2 play a key role in viral hepatitis. The imbalance between Th1 and Th2 can result in chronic viral hepatitis. In order to provide new insight for the treatment of chronic viral hepatitis, We reviewed Th1/Th2 and their related eytokines in hepatitis B and hepatitis C clinical trials were and the treatment of progress of using single cytokine to correct Th1/Th2 in the chronic hepatitis B and hepatitis C.
作者 吴昊 余永胜
出处 《国际免疫学杂志》 CAS 北大核心 2009年第2期163-166,共4页 International Journal of Immunology
关键词 辅助性T细胞 乙型肝炎 丙型肝炎 T Helper Cells Hepatitis B Hepatitis C
  • 相关文献

参考文献23

  • 1Mendoza L. A network model for the control of the diferentiation process in Th cells. BioSystems,2006, 84(2) :101-114.
  • 2Beckebaum S ,Cicinnati VR ,Zhang X,et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro : mechanisms for viral immune escape. Immunology, 2003, 109(4) :487-495.
  • 3Barth H ,Klein R ,Berg PA ,ct al . Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection. Hepatogastroenterology, 2003,50(49) : 201- 206.
  • 4Nishikomori R, Usui T, Wu CY,et al. Activated STAT4 has an essential role in Thl differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. Journal of Immunology,2002,169(8) :4388-4398.
  • 5Chakir H, Wang H, Lefebvre DE ; et al. T-bet/GATA-3 ratio as a measure of theThl/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. Immunol Methods,2003,278 (12) : 157-169.
  • 6Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell,2001,106 ( 3 ) : 259-262.
  • 7Tanaka H, Demeure CE, Rubio M, et al. Human Monocyte-derived Dendritic Ceils Induce Naive T Cell Differentiation into T Helper Cell Type 2 (Th2) or Th1/Th2 Effeetors: Role of Stimulator/Responder Ratio. J Exp Med, 2000, 192(3) :405-412.
  • 8Priimiagi LS, Tefanova VT, Tallo TG, et al. Th1-cytokines in chronic hepatitis B and C. Vopr Virusol, 2002,47 (3) :23 - 27.
  • 9Weng H, Mertens PR, Gressner AM, et al. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. Hepatol,2007,46 (2) :295 -303.
  • 10Jiang RL, Feng XR, Guo YB, et al. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J, 2002,115 ( 3 ) : 422-424.

二级参考文献16

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2贾因棠,魏来.丙型肝炎病毒非结构基因复制子模型的建立和应用[J].中华肝脏病杂志,2005,13(2):158-160. 被引量:2
  • 3Pestka S, Langer JA, Zoon KC, et aL lntefferons and their actions.Annu Rev Biochem, 1987, 56: 727-777.
  • 4Global surveillance and control of hepatitis C. Report of a WHO consultation organized in coUabomtion with the viral hepatitis C prevention board, Antwerp, Belgium J Viral Hepatol, 1999, 6 : 35-47.
  • 5McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis, 1999, 19:57-65.
  • 6Moradpour D, Blum HE. Current and evolving therapies for hepatitis C. Eur Gastroenterol Hepatol, 1999, 11 : 1199-1202.
  • 7Luxon BA, Grace M, Brassard D, et al. Pegylated interferons for the treatment of chronic hepatitis C infection. Clin Ther, 2002, 24:1363-1383.
  • 8Lohamnn V, Komer F, Koch JO, et al Repliction of subgenomic hepatitis C virus RNA in a hepatoma cell line. Science, 1999, 285 :110-113.
  • 9Blight K J, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science, 2000, 290: 1972-1974.
  • 10Horscroft N, Lai VC, Cheney W, et al. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.Anfivir Chem Chemother, 2005,16 : 1-12.

共引文献6

同被引文献10

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部